Table 1 Characteristics of the study sample
From: Medical cannabis authorization and the risk of cardiovascular events: a longitudinal cohort study
Characteristics | Controls N = 51,243 (%) | Patients authorized to use cannabis N = 18,653 (%) | ||
|---|---|---|---|---|
Age, years | ||||
< 21 | 331 | (0.65) | 119 | (0.64) |
21–30 | 5578 | (10.89) | 1972 | (10.57) |
31–40 | 10,088 | (19.69) | 3822 | (19.32) |
41–50 | 10,545 | (20.58) | 4842 | (20.49) |
51–60 | 13,227 | (25.81) | 2858 | (25.96) |
61–70 | 7771 | (15.16) | 1050 | (15.32) |
71–80 | 2745 | (5.36) | 1050 | (5.63) |
> 81 | 958 | (1.87) | 386 | (2.07) |
Sex | ||||
Female | 23,206 | (45.29) | 8528 | (45.72) |
Male | 28,037 | (54.71) | 10,125 | (54.28) |
Nearest census based neighbourhood income quintile | ||||
1 | 10,943 | (21.36) | 4053 | (21.73) |
2 | 10,524 | (20.54) | 3859 | (20.69) |
3 | 9943 | (19.40) | 3595 | (19.27) |
4 | 10,327 | (20.15) | 3726 | (19.98) |
5 | 9506 | (18.55) | 3420 | (18.33) |
Rural | 6046 | (11.80) | 1798 | (9.64) |
Comorbidities considered in the initial matching | ||||
Asthma | 9478 | (18.50) | 3690 | (19.78) |
Behavioural disorders | 8800 | (17.17) | 3573 | (19.16) |
Cancer | 4472 | (8.73) | 1828 | (9.80) |
Congestive heart failure | 295 | (0.58) | 166 | (0.89) |
Chronic obstructive pulmonary disease | 5722 | (11.17) | 2351 | (12.60) |
Diabetes | 5390 | (10.52) | 2214 | (11.87) |
Fatigue | 460 | (0.90) | 277 | (1.49) |
Metabolic disease | 5945 | (11.60) | 2605 | (13.97) |
Musculoskeletal disorders | 21,716 | (42.38) | 8250 | (44.23) |
Neurological disorders | 6812 | (13.29) | 2886 | (15.47) |
ED or hospitalization with a main diagnosis code for ACS or stroke before the index date | 483 | (0.94) | 210 | (1.13) |
History of ACS or stroke before* | 3097 | 6.04 | 1429 | 7.66 |
History of any cardiovascular event** | 14,902 | (29.08) | 6302 | (33.79) |